Bullock Wealth Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93K Buy
305
+1
+0.3% +$15 ﹤0.01% 501
2026
Q1
$4.15K Hold
304
– – ﹤0.01% 515
2025
Q4
$3.78K Buy
304
+1
+0.3% +$11 ﹤0.01% 489
2025
Q3
$3.06K Hold
303
– – ﹤0.01% 510
2025
Q2
$2.78K Buy
303
+1
+0.3% +$8 ﹤0.01% 487
2025
Q1
$2.6K Buy
302
+1
+0.3% +$10 ﹤0.01% 483
2024
Q4
$3.75K Hold
301
– – ﹤0.01% 466
2024
Q3
$3.46K Buy
301
+1
+0.3% +$12 ﹤0.01% 455
2024
Q2
$3.18K Hold
300
– – ﹤0.01% 438
2024
Q1
$3.58K Buy
+300
New +$3.61K ﹤0.01% 445

Other funds holding VTRS

Bullock Wealth Management's VTRS Position: Q2 2026 in Review

Bullock Wealth Management increased its Viatris (VTRS) stake by 0.33% in Q2 2026, buying an estimated $15 and bringing the position to 305 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Bullock Wealth Management first reported a position in VTRS in Q1 2024 and has held it in 10 quarters since. 1,033 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Bullock Wealth Management held 305 shares of Viatris worth $4.93K as of Q2 2026.
  • Bullock Wealth Management bought 1 Viatris share in Q2 2026, an estimated $15.
  • Viatris made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #501 holding.
  • Bullock Wealth Management first reported a position in Viatris in Q1 2024 and has held it in 10 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.